- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/08 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Patent holdings for IPC class A61P 5/08
Total number of patents in this class: 71
10-year publication summary
|
4
|
2
|
2
|
1
|
4
|
4
|
6
|
5
|
4
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Intellectual Property GmbH | 2522 |
8 |
| Antisense Therapeutics Ltd. | 29 |
4 |
| Crinetics Pharmaceuticals, Inc. | 117 |
4 |
| Spruce Biosciences, Inc. | 33 |
4 |
| Endo Pharmaceuticals Solutions Inc. | 22 |
3 |
| The Regents of the University of California | 19812 |
2 |
| Bayer Schering Pharma AG | 400 |
2 |
| Aeterna Zentaris GmbH | 49 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 186 |
2 |
| ISR Immune System Regulation AB | 2 |
2 |
| Edix SA | 10 |
2 |
| Amryt Endo, Inc. | 6 |
2 |
| Novartis AG | 10904 |
1 |
| Mars, Incorporated | 2930 |
1 |
| Centre National de La Recherche Scientifique | 10321 |
1 |
| Abbvie Inc. | 1802 |
1 |
| University of Southern California | 2104 |
1 |
| Beijing Neurosurgical Institute | 32 |
1 |
| Biotropics Malaysia Bhd | 21 |
1 |
| Dicerna Pharmaceuticals, Inc. | 219 |
1 |
| Other owners | 26 |